Cite
Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma
MLA
Ying Xiong, et al. “Enhancement of Siglec-8 Expression Predicts Adverse Prognosis in Patients with Clear Cell Renal Cell Carcinoma.” Urologic Oncology: Seminars and Original Investigations, vol. 35, Oct. 2017, p. 607.e1-607.e8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f665f5bed9de1fcc50535872a82eaa2&authtype=sso&custid=ns315887.
APA
Ying Xiong, Wei Xi, Jiajun Wang, Chenzhang Ou, Jianming Guo, Siyuan Dai, Jiejie Xu, Yang Qu, & Li Liu. (2017). Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations, 35, 607.e1-607.e8.
Chicago
Ying Xiong, Wei Xi, Jiajun Wang, Chenzhang Ou, Jianming Guo, Siyuan Dai, Jiejie Xu, Yang Qu, and Li Liu. 2017. “Enhancement of Siglec-8 Expression Predicts Adverse Prognosis in Patients with Clear Cell Renal Cell Carcinoma.” Urologic Oncology: Seminars and Original Investigations 35 (October): 607.e1-607.e8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f665f5bed9de1fcc50535872a82eaa2&authtype=sso&custid=ns315887.